purpos
studi
investig
featur
oncolog
patient
confirm
middl
east
respiratori
syndrom
mer
ministri
nation
guard
health
affairsriyadh
outbreak
june
determin
clinic
cours
outcom
affect
patient
method
patient
demograph
inform
cancer
histori
treatment
pattern
inform
merscoronaviru
cov
infect
histori
travel
clinic
symptom
test
result
outcom
collect
analyz
part
qualiti
improv
project
improv
care
safeti
patient
patient
confirm
infect
includ
total
patient
identifi
median
age
year
rang
year
patient
male
common
underli
diseas
hematolog
malign
follow
colorect
cancer
lung
cancer
hypertens
diabet
mellitu
common
comorbid
respect
infect
diagnos
nasopharyng
swab
patient
patient
contract
infect
hospit
reason
sixteen
patient
admit
intens
care
unit
patient
acut
respiratori
distress
syndrom
intub
acut
renal
injuri
requir
dialysi
patient
earlystag
cancer
surviv
patient
hematolog
malign
advanc
solid
tumor
case
fatal
rate
major
caus
death
due
multiorgan
failur
septic
shock
conclus
merscov
infect
result
high
case
fatal
rate
patient
malign
therefor
critic
implement
effect
primari
prevent
measur
avoid
exposur
patient
cancer
viru
jco
global
oncol
sinc
isol
novel
coronaviru
cov
middl
east
respiratori
syndrom
mer
cov
saudi
arabia
multipl
outbreak
viru
occur
insid
outsid
kingdom
includ
report
infect
least
countri
merscov
outbreak
occur
riyadh
june
led
closur
ministri
nation
guard
health
affair
hospit
outbreak
affect
mani
patient
health
care
worker
requir
systemat
approach
success
contain
outbreak
resum
full
organiz
servic
patient
cancer
usual
suscept
infecti
diseas
known
infect
lead
caus
death
among
patient
popul
multipl
caus
vulner
patient
cancer
relat
mainli
factor
underli
diseas
cancerdirect
treatment
underli
comorbid
underli
malign
may
result
weaken
immun
system
due
neg
effect
immun
cell
affect
quantiti
qualiti
case
leukemia
lymphoma
cancer
therapi
whether
surgeri
radiotherapi
chemotherapi
disturb
immun
system
variou
way
result
increas
risk
infect
patient
cancer
like
comorbid
whether
due
age
exposur
cancer
risk
factor
smoke
obes
lifestyl
choic
chronic
diseas
comorbid
identifi
previous
risk
factor
merscov
mortal
factor
lead
predisposit
patient
cancer
high
risk
acquir
infecti
diseas
wors
outcom
patient
without
cancer
oncolog
patient
affect
merscov
outbreak
sadli
mani
die
outcom
oncolog
patient
affect
merscov
infect
report
independ
chronic
diseas
articl
describ
characterist
outcom
oncolog
patient
infect
viru
institut
outbreak
perform
retrospect
review
medic
record
elig
patient
retriev
follow
variabl
patient
demograph
cancer
histori
treatment
pattern
inform
merscov
infect
histori
travel
clinic
symptom
test
result
surviv
statu
oncolog
patient
laboratoryconfirm
merscov
infect
june
septemb
includ
analysi
descript
statist
use
analyz
demograph
diseas
characterist
present
treatment
use
health
care
resourc
surviv
statu
overal
surviv
os
determin
onset
symptom
date
death
caus
loss
followup
patient
still
aliv
time
analysi
censor
date
last
contact
kaplanmei
method
use
estim
os
ci
median
time
os
inferenti
analysi
perform
appli
univari
analysi
examin
associ
surviv
statu
patient
demograph
clinic
characterist
test
use
compar
proport
nomin
categor
variabl
test
use
continu
variabl
p
valu
consid
signific
total
patient
infect
merscov
hospit
health
care
worker
nineteen
patient
confirm
cancer
diagnosi
identifi
includ
report
patient
characterist
describ
tabl
major
patient
male
median
age
year
approxim
half
patient
hematolog
malign
major
solid
tumor
malign
advanc
stage
patient
comorbid
almost
one
third
patient
receiv
activ
treatment
activ
diseas
time
infect
tabl
dyspnea
common
symptom
follow
fever
cough
gi
symptom
diarrhea
vomit
main
symptom
outsid
respiratori
system
tabl
sixteen
patient
admit
intens
care
unit
icu
patient
acut
respiratori
distress
syndrom
intub
acut
renal
injuri
requir
dialysi
tabl
compar
patient
undergo
cancer
treatment
versu
nonact
treatment
signific
differ
identifi
group
respect
icu
admiss
patient
outcom
sixteen
patient
die
result
diseas
multiorgan
failur
sepsi
common
caus
death
tabl
median
time
onset
respiratori
symptom
icu
admiss
day
median
surviv
onset
symptom
day
patient
surviv
univari
analysi
show
signific
associ
surviv
statu
stage
cancer
p
late
stage
hematolog
malign
predomin
factor
patient
die
activ
diseas
significantli
associ
high
fatal
rate
p
tabl
studi
reveal
high
fatal
rate
patient
cancer
infect
merscov
reach
patient
hematolog
malign
advancedstag
solid
tumor
doubl
risk
compar
death
rate
among
patient
hospit
report
literatur
rang
although
report
mortal
rate
oncolog
patient
korean
studi
reveal
death
rate
patient
chronic
comorbid
includ
cancer
high
fatal
rate
explain
natur
underli
diseas
describ
outcom
oncolog
patient
confirm
merscov
infect
outbreak
saudi
arabia
knowledg
gener
outbreak
oncolog
patient
confirm
infect
viru
three
patient
surviv
ill
case
fatal
rate
cfr
doubl
cfr
nononcolog
patient
cfr
reach
patient
advanc
cancer
hematolog
malign
relev
extra
precaut
taken
protect
patient
cancer
exposur
infecti
pathogen
outbreak
primari
prevent
vaccin
dire
need
comorbid
signific
find
dictat
need
implement
extra
precaut
measur
ensur
vulner
patient
expos
viru
import
factor
note
patient
popul
studi
less
one
third
patient
initi
present
fever
fraction
consid
small
compar
previous
report
studi
conduct
saudi
arabia
alhasa
makkah
riyadh
studi
report
malign
diseas
one
comorbid
studi
popul
find
identifi
fever
reliabl
symptom
suspicion
merscov
infect
patient
cancer
previou
predictor
age
year
previou
merscov
outbreak
found
signific
variabl
studi
popul
among
patient
cancer
advancedstag
hematolog
malign
appear
associ
case
fatal
rate
survivor
earlystag
solid
tumor
limit
studi
small
number
patient
retrospect
natur
studi
design
studi
account
asymptomat
undiagnos
infect
patient
may
recov
patient
die
without
confirm
diagnosi
prudent
ensur
possibl
precautionari
measur
implement
protect
oncolog
patient
